Invokana And Its Potential Dangers
Invokana is a medication marketed by Janssen (a subsidiary of Johnson & Johnson) designed to treat Type 2 diabetes. It’s advertised as a proven reducer of blood sugar levels in Type 2 diabetes sufferers. It also claims that some patients have seen a modest reduction in blood pressure from taking the drug.
The drug has been in use since 2013, and is the first subtype 2 sodium-glucose transport inhibitor on the market to treat Type 2 diabetes.
Unfortunately, several severe side effects and complications have been detected in Invokana patients in the years since its introduction. These include increased risk of:
- Toe, foot and leg amputation
- Kidney failure, which can be fatal or lead to the need for dialysis
- Ketoacidosis, a buildup of toxic acid in the bloodstream that can cause coma or even death
In 2017, the FDA required a more pronounced warning of the increased risk of amputations on Invokana’s packaging. However, many others have already experienced these horrible side effects from taking a drug that may have been rushed to market and did not undergo the proper testing.
At Young Conaway Stargatt & Taylor, LLP, our attorneys have a long track record of holding drug manufacturers accountable for placing profits above patient safety. We can conduct a thorough investigation into your case and help you determine your options for pursuing compensation.
Experienced Injury Lawyers Are Ready To Fight For You. Call Today For Help.
If you or a loved one is suffering needlessly from the dangerous side effects of Invokana, our lawyers can help you determine whether you deserve compensation. To learn more, schedule a free consultation online or call us at 302-298-0370. We serve clients across Delaware from our office in Wilmington.